ADMP Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Adamis Pharmaceuticals is a specialty biopharmaceutical company. Co. develops and commercializes products in the therapeutic areas of respiratory disease and allergy. Co.'s products and product candidates include: Symjepi™ Injection 0.3mg for the treatment of acute allergic reactions and anaphylaxis; Symjepi™ Injection 0.15mg for the treatment of anaphylaxis for patients weighing 33-65 pounds; a naloxone injection product candidate for the treatment of opioid overdose; and, a beclomethasone metered dose inhaler and fluticasone dry powder inhaler for the treatment of asthma. Co. also provides prescription compounded medications, to patients, physician, and among others throughout the U.S. According to our Adamis Pharmaceuticals stock split history records, Adamis Pharmaceuticals has had 1 split.
Adamis Pharmaceuticals stock split history picture
Adamis Pharmaceuticals (ADMP) has 1 split in our Adamis Pharmaceuticals stock split history database. The split for ADMP took place on December 13, 2013. This was a 1 for 17 reverse split, meaning for each 17 shares of ADMP owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 58.8235294117647 share position following the split.

When a company such as Adamis Pharmaceuticals conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share. Looking at the Adamis Pharmaceuticals stock split history from start to finish, an original position size of 1000 shares would have turned into 58.8235294117647 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Adamis Pharmaceuticals shares, starting with a $10,000 purchase of ADMP, presented on a split-history-adjusted basis factoring in the complete Adamis Pharmaceuticals stock split history. Adamis Pharmaceuticals split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 11/20/2008
End date: 11/19/2018
Start price/share: $0.68
End price/share: $2.50
Dividends collected/share: $0.00
Total return: 267.65%
Average Annual Total Return: 13.90%
Starting investment: $10,000.00
Ending investment: $36,761.40
Years: 10.00
Date Ratio
12/13/20131 for 17
ADMP is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

ADMS Split History
ADPT Split History
ADXS Split History
AEZS Split History
AFAM Split History
AFFX Split History
AGN Split History
AHPI Split History
AIMT Split History
AIQ Split History

Also explore: ADMP shares outstanding history

More latest
Funds Holding Adamis Pharmaceuticals
Adamis Pharmaceuticals Insider Buying